CASI Pharmaceuticals Inc
NASDAQ:CASI 3:59:55 PM EDT
| Market Cap (Intraday) | 93.11M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.73 |
| 50-Day MA | $0.86 |
| 200-Day MA | $1.29 |
CASI Pharmaceuticals Inc Stock, NASDAQ:CASI
9620 Medical Center Drive, Suite 300, Rockville, Maryland 20850
United States of America
Phone: +1.240.864.2600
Number of Employees: 144
Description
CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.